These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36997007)

  • 1. Assessment of anti-inflammatory efficacy of acupuncture in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Yang X; He M; Tang Q; Wang Z; Jin D; Wu X; Yang Y; Ma D; Sun M; Li T
    Complement Ther Med; 2023 Jun; 74():102946. PubMed ID: 36997007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture for inflammatory bowel disease: A protocol for systematic review and meta-analysis.
    Yang X; Sun M; He M; Wang Z; Tang Q; Li T
    Medicine (Baltimore); 2022 Dec; 101(49):e32236. PubMed ID: 36626462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M
    Pharmacol Res; 2019 Oct; 148():104290. PubMed ID: 31185284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network meta-analysis of curative efficacy of different acupuncture methods on obesity combined with insulin resistance.
    Chen J; Gu Y; Yin L; He M; Liu N; Lu Y; Xie C; Li J; Chen Y
    Front Endocrinol (Lausanne); 2022; 13():968481. PubMed ID: 36120465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis.
    Truong SL; Chin J; Liew DFL; Zahir SF; Ryan EG; Rubel D; Radford-Smith G; Robinson PC
    Rheumatol Ther; 2021 Dec; 8(4):1603-1616. PubMed ID: 34449067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Dai C; Wang YN; Tian WN; Huang YH; Jiang M
    Int Immunopharmacol; 2022 Nov; 112():109269. PubMed ID: 36182873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases.
    Su W; Yu Y; Xu X; Wang XQ; Huang JB; Xu CD; Xiao Y
    World J Gastroenterol; 2021 Jan; 27(1):92-106. PubMed ID: 33505153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.
    Ji J; Lu Y; Liu H; Feng H; Zhang F; Wu L; Cui Y; Wu H
    Evid Based Complement Alternat Med; 2013; 2013():158352. PubMed ID: 24204388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
    Schreiber S; Heinig T; Thiele HG; Raedler A
    Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture for emotional disorders in patients with inflammatory bowel disease: a systematic review protocol.
    Zhou YF; Zhang GL; Sun N; Wang ZQ; Ye XY; Xiong J; Deng XD; Lin X; Zhang P; Zheng H; Zhang Y; Yang K; Gao ZD; Sun RR; Liang FR
    BMJ Open; 2022 Sep; 12(9):e058568. PubMed ID: 36167375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis.
    Dai ZH; Xu XT; Ran ZH
    Ann Pharmacother; 2020 Aug; 54(8):729-741. PubMed ID: 31955605
    [No Abstract]   [Full Text] [Related]  

  • 13. Acupuncture therapy for poststroke spastic hemiplegia: A systematic review and meta-analysis of randomized controlled trials.
    Fan W; Kuang X; Hu J; Chen X; Yi W; Lu L; Xu N; Wang L
    Complement Ther Clin Pract; 2020 Aug; 40():101176. PubMed ID: 32347210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy.
    Nigam GB; Bhandare AP; Antoniou GA; Limdi JK
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):346-357. PubMed ID: 32889976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India.
    Ahirwar DK; Kesarwani P; Singh R; Ghoshal UC; Mittal RD
    J Gastrointest Cancer; 2012 Jun; 43(2):196-204. PubMed ID: 21249467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of acupuncture as a complementary therapy for sepsis: a systematic review and meta-analysis.
    Xian J; Wang L; Zhang C; Wang J; Zhu Y; Yu H; Zhang X; Tan Q
    Acupunct Med; 2023 Feb; 41(1):3-15. PubMed ID: 35579024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents.
    Yamada A; Wang J; Komaki Y; Komaki F; Micic D; Sakuraba A
    Aliment Pharmacol Ther; 2019 Aug; 50(4):373-385. PubMed ID: 31309607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice.
    Jung WY; Kang JH; Kim KG; Kim HS; Jang BI; Park YH; Song IH
    Tissue Cell; 2015 Feb; 47(1):86-93. PubMed ID: 25544730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.